{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:36:19Z","timestamp":1782909379605,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["01E00802"],"award-info":[{"award-number":["01E00802"]}]},{"name":"Immunotherapy Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adoptive transfer of virus-specific T cells (VSTs) represents a prophylactic and curative approach for opportunistic viral infections and reactivations after transplantation. However, inadequate frequencies of circulating memory VSTs in the T-cell donor\u2019s peripheral blood often result in insufficient enrichment efficiency and purity of the final T-cell product, limiting the effectiveness of this approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This pilot study was designed as a cross-over trial and compared the effect of a single bout (30\u00a0min) of high-intensity interval training (HIT) with that of 30\u00a0min of continuous exercise (CONT) on the frequency and function of circulating donor VSTs. To this end, we used established immunoassays to examine the donors\u2019 cellular immune status, in particular, with respect to the frequency and specific characteristics of VSTs restricted against Cytomegalovirus (CMV)-, Epstein\u2013Barr-Virus (EBV)- and Adenovirus (AdV)-derived antigens. T-cell function, phenotype, activation and proliferation were examined at different time points before and after exercise to identify the most suitable time for T-cell donation. The clinical applicability was determined by small-scale T-cell enrichment using interferon- (IFN-) \u03b3 cytokine secretion assay and virus-derived overlapping peptide pools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HIT proved to be the most effective exercise program with up to fivefold higher VST response. In general, donors with a moderate fitness level had higher starting and post-exercise frequencies of VSTs than highly fit donors, who showed significantly lower post-exercise increases in VST frequencies. Both exercise programs boosted the number of VSTs against less immunodominant antigens, specifically CMV (IE-1), EBV (EBNA-1) and AdV (Hexon, Penton), compared to VSTs against immunodominant antigens with higher memory T-cell frequencies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrates that exercise before T-cell donation has a beneficial effect on the donor\u2019s cellular immunity with respect to the proportion of circulating functionally active VSTs. We conclude that a single bout of HIT exercise 24\u00a0h before T-cell donation can significantly improve manufacturing of clinically applicable VSTs. This simple and economical adjuvant treatment proved to be especially efficient in enhancing virus-specific memory T cells with low precursor frequencies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-020-02301-3","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T13:03:23Z","timestamp":1585746203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-intensity interval training in allogeneic adoptive T-cell immunotherapy \u2013 a big HIT?"],"prefix":"10.1186","volume":"18","author":[{"given":"Nele Carolin","family":"Heinemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tischer-Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torge Christian","family":"Wittke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Eigendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Kerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Framke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Melk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gert","family":"Heuft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Maecker-Kolhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Eiz-Vesper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2301_CR1","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.5","volume":"4","author":"CL Holmes-Liew","year":"2015","unstructured":"Holmes-Liew CL, Holmes M, Beagley L, Hopkins P, Chambers D, Smith C, Khanna R. Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation. Clin Transl Immunol. 2015;4:e35.","journal-title":"Clin Transl Immunol"},{"key":"2301_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13045-017-0469-0","volume":"10","author":"C Qian","year":"2017","unstructured":"Qian C, Campidelli A, Wang Y, Cai H, Venard V, Jeulin H, Dalle JH, Pochon C, D\u2019Aveni M, Bruno B, et al. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I\/II multicenter clinical trial. J Hematol Oncol. 2017;10:102.","journal-title":"J Hematol Oncol"},{"key":"2301_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ, Center for International B, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143\u2013238.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2301_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, Einsele H, Cordonnier C, Acute, Chronic Leukemia Working P, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36:757\u201369.","journal-title":"Bone Marrow Transplant"},{"key":"2301_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","volume":"12","author":"T Kaeuferle","year":"2019","unstructured":"Kaeuferle T, Krauss R, Blaeschke F, Willier S, Feuchtinger T. Strategies of adoptive T-cell transfer to treat refractory viral infections post allogeneic stem cell transplantation. J Hematol Oncol. 2019;12:13.","journal-title":"J Hematol Oncol"},{"key":"2301_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","volume":"9","author":"N Symeonidis","year":"2007","unstructured":"Symeonidis N, Jakubowski A, Pierre-Louis S, Jaffe D, Pamer E, Sepkowitz K, O\u2019Reilly RJ, Papanicolaou GA. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis. 2007;9:108\u201313.","journal-title":"Transpl Infect Dis"},{"key":"2301_CR7","first-page":"1435","volume":"19","author":"J Marinho-Dias","year":"2019","unstructured":"Marinho-Dias J, Baldaque I, Pinho-Vaz C, Leite L, Branca R, Campilho F, Campos A Jr, Medeiros R, Sousa H. Association of EpsteinBarr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal. Mol Med Rep. 2019;19:1435\u201342.","journal-title":"Mol Med Rep"},{"key":"2301_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1590\/0037-8682-0036-2014","volume":"47","author":"HH Marques","year":"2014","unstructured":"Marques HH, Shikanai-Yasuda MA, dAzevedo LS, Caiaffa-Filho HH, Pierrotti LC, Aquino MZ, Lopes MH, Maluf NZ, Campos SV, Costa SF. Management of post-transplant Epstein\u2013Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients. Rev Soc Bras Med Trop. 2014;47:543\u20136.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"2301_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.htct.2018.10.004","volume":"42","author":"L Diaz","year":"2019","unstructured":"Diaz L, Rosales J, Rosso F, Rosales M, Estacio M, Manzi E, Jaramillo FJ. Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8\u00a0years. Hematol Transfus Cell Ther. 2019;42(1):18\u201324. https:\/\/doi.org\/10.1016\/j.htct.2018.10.004.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"1121","key":"2301_CR10","first-page":"e1129-1115","volume":"21","author":"J Liu","year":"2015","unstructured":"Liu J, Kong J, Chang YJ, Chen H, Chen YH, Han W, Wang Y, Yan CH, Wang JZ, Wang FR, et al. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect. 2015;21(1121):e1129-1115.","journal-title":"Clin Microbiol Infect"},{"key":"2301_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","volume":"17","author":"JA Fishman","year":"2017","unstructured":"Fishman JA. Infection in organ transplantation. Am J Transplant. 2017;17:856\u201379.","journal-title":"Am J Transplant"},{"key":"2301_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","volume":"45","author":"P Ramanan","year":"2013","unstructured":"Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013;45:260\u201371.","journal-title":"Infect Chemother"},{"key":"2301_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/ajt.12640","volume":"14","author":"S Choquet","year":"2014","unstructured":"Choquet S, Varnous S, Deback C, Golmard JL, Leblond V. Adapted treatment of Epstein\u2013Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation. Am J Transplant. 2014;14(4):857\u201366.","journal-title":"Am J Transplant"},{"key":"2301_CR14","doi-asserted-by":"publisher","first-page":"e2019001","DOI":"10.4084\/mjhid.2019.001","volume":"11","author":"JJ Frietsch","year":"2019","unstructured":"Frietsch JJ, Michel D, Stamminger T, Hunstig F, Birndt S, Schnetzke U, Scholl S, Hochhaus A, Hilgendorf I. In vivo emergence of UL56 C325Y cytomegalovirus resistance to letermovir in a patient with acute myeloid leukemia after hematopoietic cell transplantation. Mediterr J Hematol Infect Dis. 2019;11:e2019001.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2301_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1200\/JCO.2012.43.5784","volume":"31","author":"CM Bollard","year":"2013","unstructured":"Bollard CM. Improving T-cell therapy for epstein-barr virus lymphoproliferative disorders. J Clin Oncol. 2013;31:5\u20137.","journal-title":"J Clin Oncol"},{"key":"2301_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/CCO.0000000000000119","volume":"26","author":"J Sanz","year":"2014","unstructured":"Sanz J, Andreu R. Epstein\u2013Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation. Curr Opin Oncol. 2014;26:677\u201383.","journal-title":"Curr Opin Oncol"},{"key":"2301_CR17","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood-2016-11-749721","volume":"129","author":"P Hiwarkar","year":"2017","unstructured":"Hiwarkar P, Amrolia P, Sivaprakasam P, Lum SH, Doss H, O\u2019Rafferty C, Petterson T, Patrick K, Silva J, Slatter M, et al. Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant. Blood. 2017;129:2033\u20137.","journal-title":"Blood"},{"key":"2301_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","volume":"134","author":"T Feuchtinger","year":"2006","unstructured":"Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, Handgretinger R, Peters C, Schuster FR, Beck R, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134:64\u201376.","journal-title":"Br J Haematol"},{"key":"2301_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbmt.2003.09.017","volume":"10","author":"CM Bollard","year":"2004","unstructured":"Bollard CM, Kuehnle I, Leen A, Rooney CM, Heslop HE. Adoptive immunotherapy for posttransplantation viral infections. Biol Blood Marrow Transplant. 2004;10:143\u201355.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2301_CR20","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1182\/bloodadvances.2019000201","volume":"3","author":"AA Abraham","year":"2019","unstructured":"Abraham AA, John TD, Keller MD, Cruz CRN, Salem B, Roesch L, Liu H, Hoq F, Grilley BJ, Gee AP, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3:2057\u201368.","journal-title":"Blood Adv"},{"key":"2301_CR21","first-page":"278","volume":"3","author":"RJ Arasaratnam","year":"2015","unstructured":"Arasaratnam RJ, Leen AM. Adoptive T cell therapy for the treatment of viral infections. Ann Transl Med. 2015;3:278.","journal-title":"Ann Transl Med"},{"issue":"10","key":"2301_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41409-018-0209-2","volume":"53","author":"M Lindemann","year":"2018","unstructured":"Lindemann M, Eiz-Vesper B, Steckel NK, Tischer S, Fiedler M, Heinold A, Klisanin V, Maecker-Kolhoff B, Blasczyk R, Horn PA, et al. Adoptive transfer of cellular immunity against cytomegalovirus by virus-specific lymphocytes from a third-party family donor. Bone Marrow Transplant. 2018;53(10):1351\u20135. https:\/\/doi.org\/10.1038\/s41409-018-0209-2.","journal-title":"Bone Marrow Transplant."},{"key":"2301_CR23","first-page":"S4","volume":"3","author":"B Maecker-Kolhoff","year":"2015","unstructured":"Maecker-Kolhoff B, Eiz-Vesper B. Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation. Ann Transl Med. 2015;3:S4.","journal-title":"Ann Transl Med"},{"key":"2301_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/bmt.2017.232","volume":"53","author":"C Qian","year":"2018","unstructured":"Qian C, Wang Y, Reppel L, D\u2019Aveni M, Campidelli A, Decot V, Bensoussan D. Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT. Bone Marrow Transplant. 2018;53:114\u201322.","journal-title":"Bone Marrow Transplant"},{"key":"2301_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","volume":"51","author":"A Schmitt","year":"2011","unstructured":"Schmitt A, Tonn T, Busch DH, Grigoleit GU, Einsele H, Odendahl M, Germeroth L, Ringhoffer M, Ringhoffer S, Wiesneth M, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion. 2011;51:591\u20139.","journal-title":"Transfusion"},{"issue":"1","key":"2301_CR26","doi-asserted-by":"publisher","first-page":"e13201","DOI":"10.1111\/tid.13201","volume":"22","author":"RE Schultze-Florey","year":"2020","unstructured":"Schultze-Florey RE, Tischer-Zimmermann S, Heuft HG, Priesner C, Lamottke B, Heim A, Sauer M, Sykora KW, Blasczyk R, Eiz-Vesper B, Maecker-Kolhoff B. Transfer of hexon- and penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation. Transpl Infect Dis. 2020;22(1):e13201. https:\/\/doi.org\/10.1111\/tid.13201.","journal-title":"Transpl Infect Dis."},{"key":"2301_CR27","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3389\/fimmu.2018.01475","volume":"9","author":"RE Schultze-Florey","year":"2018","unstructured":"Schultze-Florey RE, Tischer S, Kuhlmann L, Hundsdoerfer P, Koch A, Anagnostopoulos I, Ravens S, Goudeva L, Schultze-Florey C, Koenecke C, et al. Dissecting Epstein\u2013Barr virus-specific T-cell responses after allogeneic EBV-specific T-cell transfer for central nervous system posttransplant lymphoproliferative disease. Front Immunol. 2018;9:1475.","journal-title":"Front Immunol"},{"key":"2301_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fimmu.2016.00393","volume":"7","author":"C Priesner","year":"2016","unstructured":"Priesner C, Esser R, Tischer S, Marburger M, Aleksandrova K, Maecker-Kolhoff B, Heuft HG, Goudeva L, Blasczyk R, Arseniev L, et al. Comparative analysis of clinical-scale IFN-gamma-positive T-cell enrichment using partially and fully integrated platforms. Front Immunol. 2016;7:393.","journal-title":"Front Immunol"},{"key":"2301_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-014-0336-5","volume":"12","author":"S Tischer","year":"2014","unstructured":"Tischer S, Priesner C, Heuft HG, Goudeva L, Mende W, Barthold M, Kloess S, Arseniev L, Aleksandrova K, Maecker-Kolhoff B, et al. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. J Transl Med. 2014;12:336.","journal-title":"J Transl Med"},{"key":"2301_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1055\/s-0033-1333749","volume":"225","author":"J Feucht","year":"2013","unstructured":"Feucht J, Joachim L, Lang P, Feuchtinger T. Adoptive T-cell transfer for refractory viral infections with cytomegalovirus, Epstein\u2013Barr virus or adenovirus after allogeneic stem cell transplantation. Klin Padiatr. 2013;225:164\u20139.","journal-title":"Klin Padiatr"},{"key":"2301_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/CJI.0000000000000034","volume":"37","author":"R Geyeregger","year":"2014","unstructured":"Geyeregger R, Freimuller C, Stemberger J, Artwohl M, Witt V, Lion T, Fischer G, Lawitschka A, Ritter J, Hummel M, et al. First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation. J Immunother. 2014;37:245\u20139.","journal-title":"J Immunother"},{"key":"2301_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/CJI.0000000000000197","volume":"41","author":"K Kallay","year":"2018","unstructured":"Kallay K, Kassa C, Reti M, Karaszi E, Sinko J, Goda V, Strehn A, Csordas K, Horvath O, Szederjesi A, et al. Early experience With CliniMACS Prodigy CCS (IFN-gamma) system in selection of virus-specific T cells from third-party donors for pediatric patients with severe viral infections after hematopoietic stem cell transplantation. J Immunother. 2018;41:158\u201363.","journal-title":"J Immunother"},{"key":"2301_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/cid\/cis625","volume":"55","author":"M Uhlin","year":"2012","unstructured":"Uhlin M, Gertow J, Uzunel M, Okas M, Berglund S, Watz E, Brune M, Ljungman P, Maeurer M, Mattsson J. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease. Clin Infect Dis. 2012;55:1064\u201373.","journal-title":"Clin Infect Dis"},{"key":"2301_CR34","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/bloodadvances.2017010223","volume":"1","author":"B Withers","year":"2017","unstructured":"Withers B, Blyth E, Clancy LE, Yong A, Fraser C, Burgess J, Simms R, Brown R, Kliman D, Dubosq MC, et al. Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells. Blood Adv. 2017;1:2193\u2013205.","journal-title":"Blood Adv"},{"key":"2301_CR35","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.bbmt.2018.08.024","volume":"24","author":"B Withers","year":"2018","unstructured":"Withers B, Clancy L, Burgess J, Simms R, Brown R, Micklethwaite K, Blyth E, Gottlieb D. Establishment and operation of a third-party virus-specific T cell bank within an allogeneic stem cell transplant program. Biol Blood Marrow Transplant. 2018;24:2433\u201342.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2301_CR36","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","volume":"127","author":"CM Bollard","year":"2016","unstructured":"Bollard CM, Heslop HE. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood. 2016;127(26):3331\u201340.","journal-title":"Blood"},{"key":"2301_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/bs.pmbts.2015.08.001","volume":"135","author":"RJ Simpson","year":"2015","unstructured":"Simpson RJ, Kunz H, Agha N, Graff R. Exercise and the regulation of immune functions. Prog Mol Biol Transl Sci. 2015;135:355\u201380.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2301_CR38","doi-asserted-by":"crossref","unstructured":"Belviranli M, Okudan N, Kabak B. The effects of acute high-intensity interval training on hematological parameters in sedentary subjects. Med Sci. 2017;5.","DOI":"10.3390\/medsci5030015"},{"key":"2301_CR39","doi-asserted-by":"publisher","first-page":"25852","DOI":"10.1038\/srep25852","volume":"6","author":"G Spielmann","year":"2016","unstructured":"Spielmann G, Bollard CM, Kunz H, Hanley PJ, Simpson RJ. A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy. Sci Rep. 2016;6:25852. https:\/\/doi.org\/10.1038\/srep25852.","journal-title":"Sci Rep"},{"key":"2301_CR40","first-page":"6","volume":"17","author":"NP Walsh","year":"2011","unstructured":"Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6\u201363.","journal-title":"Exerc Immunol Rev"},{"key":"2301_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.physbeh.2018.04.035","volume":"194","author":"HE Kunz","year":"2018","unstructured":"Kunz HE, Spielmann G, Agha NH, O\u2019Connor DP, Bollard CM, Simpson RJ. A single exercise bout augments adenovirus-specific T-cell mobilization and function. Physiol Behav. 2018;194:56\u201365.","journal-title":"Physiol Behav"},{"key":"2301_CR42","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1113\/jphysiol.2011.224725","volume":"590","author":"MJ Gibala","year":"2012","unstructured":"Gibala MJ, Little JP, Macdonald MJ, Hawley JA. Physiological adaptations to low-volume, high-intensity interval training in health and disease. J Physiol. 2012;590:1077\u201384.","journal-title":"J Physiol"},{"key":"2301_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/CS20080249","volume":"116","author":"AE Tjonna","year":"2009","unstructured":"Tjonna AE, Stolen TO, Bye A, Volden M, Slordahl SA, Odegard R, Skogvoll E, Wisloff U. Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci. 2009;116:317\u201326.","journal-title":"Clin Sci"},{"key":"2301_CR44","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"2301_CR45","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.18632\/oncotarget.23531","volume":"9","author":"M Bieling","year":"2018","unstructured":"Bieling M, Tischer S, Kalinke U, Blasczyk R, Buus S, Maecker-Kolhoff B, Eiz-Vesper B. Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: evaluation of novel naturally processed and presented EBV-derived T-cell epitopes. Oncotarget. 2018;9(4):4737\u20134757","journal-title":"Oncotarget."},{"key":"2301_CR46","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.bbmt.2013.07.015","volume":"19","author":"C Sukdolak","year":"2013","unstructured":"Sukdolak C, Tischer S, Dieks D, Figueiredo C, Goudeva L, Heuft HG, Verboom M, Immenschuh S, Heim A, Borchers S, et al. CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome. Biol Blood Marrow Transplant. 2013;19:1480\u201392.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2301_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jim.2014.05.011","volume":"408","author":"S Tischer","year":"2014","unstructured":"Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein\u2013Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. J Immunol Methods. 2014;408:101\u201313.","journal-title":"J Immunol Methods"},{"key":"2301_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cei.12451","volume":"179","author":"CE Bunse","year":"2015","unstructured":"Bunse CE, Fortmeier V, Tischer S, Zilian E, Figueiredo C, Witte T, Blasczyk R, Immenschuh S, Eiz-Vesper B. Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses. Clin Exp Immunol. 2015;179:265\u201376.","journal-title":"Clin Exp Immunol"},{"key":"2301_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0140-6736(03)12384-7","volume":"361","author":"RM Cawthon","year":"2003","unstructured":"Cawthon RM, Smith KR, O\u2019Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60\u00a0years or older. Lancet. 2003;361:393\u20135.","journal-title":"Lancet"},{"key":"2301_CR50","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ijcard.2014.07.236","volume":"176","author":"A Melk","year":"2014","unstructured":"Melk A, Tegtbur U, Hilfiker-Kleiner D, Eberhard J, Saretzki G, Eulert C, Kerling A, Nelius AK, Homme M, Strunk D, et al. Improvement of biological age by physical activity. Int J Cardiol. 2014;176:1187\u20139.","journal-title":"Int J Cardiol"},{"key":"2301_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/0470854596","volume-title":"Cross-over trials in clinical trials","author":"S Senn","year":"2002","unstructured":"Senn S. Cross-over trials in clinical trials. 2nd ed. Chichester: Wiley; 2002.","edition":"2"},{"key":"2301_CR52","first-page":"501","volume":"17","author":"AZ Jamurtas","year":"2018","unstructured":"Jamurtas AZ, Fatouros IG, Deli CK, Georgakouli K, Poulios A, Draganidis D, Papanikolaou K, Tsimeas P, Chatzinikolaou A, Avloniti A, et al. The effects of acute low-volume HIIT and aerobic exercise on leukocyte count and redox status. J Sports Sci Med. 2018;17:501\u20138.","journal-title":"J Sports Sci Med"},{"key":"2301_CR53","first-page":"43","volume":"10","author":"M Gleeson","year":"2005","unstructured":"Gleeson M, Bishop NC. The T cell and NK cell immune response to exercise. Ann Transplant. 2005;10:43\u20138.","journal-title":"Ann Transplant"},{"key":"2301_CR54","doi-asserted-by":"publisher","first-page":"e0189612","DOI":"10.1371\/journal.pone.0189612","volume":"12","author":"A Malik","year":"2017","unstructured":"Malik A, Adland E, Laker L, Kloverpris H, Fardoos R, Roider J, Severinsen MC, Chen F, Riddell L, Edwards A, et al. Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations. PLoS ONE. 2017;12:e0189612.","journal-title":"PLoS ONE"},{"key":"2301_CR55","first-page":"4234765","volume":"2017","author":"JE Turner","year":"2017","unstructured":"Turner JE, Brum PC. Does regular exercise counter T cell immunosenescence reducing the risk of developing cancer and promoting successful treatment of malignancies? Oxid Med Cell Longev. 2017;2017:4234765.","journal-title":"Oxid Med Cell Longev"},{"key":"2301_CR56","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1073\/pnas.0406867102","volume":"102","author":"B Purtic","year":"2005","unstructured":"Purtic B, Pitcher LA, van Oers NS, Wulfing C. T cell receptor (TCR) clustering in the immunological synapse integrates TCR and costimulatory signaling in selected T cells. Proc Natl Acad Sci USA. 2005;102:2904\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2301_CR57","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, Meng X, Li L, Wang J, Xu C, et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature. 2016;531:651\u20135.","journal-title":"Nature"},{"key":"2301_CR58","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fimmu.2017.01664","volume":"8","author":"A Bietz","year":"2017","unstructured":"Bietz A, Zhu H, Xue M, Xu C. Cholesterol metabolism in T cells. Front Immunol. 2017;8:1664.","journal-title":"Front Immunol"},{"key":"2301_CR59","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.immuni.2016.04.011","volume":"44","author":"M Swamy","year":"2016","unstructured":"Swamy M, Beck-Garcia K, Beck-Garcia E, Hartl FA, Morath A, Yousefi OS, Dopfer EP, Molnar E, Schulze AK, Blanco R, et al. A cholesterol-based allostery model of T cell receptor phosphorylation. Immunity. 2016;44:1091\u2013101.","journal-title":"Immunity"},{"key":"2301_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s13046-019-1409-3","volume":"38","author":"Z Yin","year":"2019","unstructured":"Yin Z, Bai L, Li W, Zeng T, Tian H, Cui J. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy. J Exp Clin Cancer Res. 2019;38:403.","journal-title":"J Exp Clin Cancer Res"},{"key":"2301_CR61","doi-asserted-by":"publisher","first-page":"e14234","DOI":"10.14814\/phy2.14234","volume":"7","author":"AK Holbrook","year":"2019","unstructured":"Holbrook AK, Peterson HD, Bianchi SA, Macdonald BW, Bredahl EC, Belshan M, Siedlik JA. CD4(+) T cell activation and associated susceptibility to HIV-1 infection in vitro increased following acute resistance exercise in human subjects. Physiol Rep. 2019;7:e14234.","journal-title":"Physiol Rep"},{"key":"2301_CR62","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12192-017-0771-3","volume":"22","author":"TG Heck","year":"2017","unstructured":"Heck TG, Scomazzon SP, Nunes PR, Scholer CM, da Silva GS, Bittencourt A, Faccioni-Heuser MC, Krause M, Bazotte RB, Curi R, Homem de Bittencourt PI Jr. Acute exercise boosts cell proliferation and the heat shock response in lymphocytes: correlation with cytokine production and extracellular-to-intracellular HSP70 ratio. Cell Stress Chaperones. 2017;22:271\u201391.","journal-title":"Cell Stress Chaperones"},{"key":"2301_CR63","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12192-014-0493-8","volume":"19","author":"PL Hooper","year":"2014","unstructured":"Hooper PL, Balogh G, Rivas E, Kavanagh K, Vigh L. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress Chaperones. 2014;19:447\u201364.","journal-title":"Cell Stress Chaperones"},{"key":"2301_CR64","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.mad.2009.12.009","volume":"131","author":"TJ LaRocca","year":"2010","unstructured":"LaRocca TJ, Seals DR, Pierce GL. Leukocyte telomere length is preserved with aging in endurance exercise-trained adults and related to maximal aerobic capacity. Mech Ageing Dev. 2010;131:165\u20137.","journal-title":"Mech Ageing Dev"},{"key":"2301_CR65","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/bmt.2016.17","volume":"51","author":"RJ O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly RJ, Prockop S, Hasan AN, Koehne G, Doubrovina E. Virus-specific T-cell banks for \u2018off the shelf\u2018 adoptive therapy of refractory infections. Bone Marrow Transplant. 2016;51:1163\u201372.","journal-title":"Bone Marrow Transplant"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-020-02301-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02301-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:13:15Z","timestamp":1617232395000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02301-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02301-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of Hannover Medical School (MHH, approval number 3366-2016). After giving their written informed consent, each participant underwent a medical check-up to exclude active infections and an electrocardiogram in rest was evaluated by an experienced cardiologist to make sure that participants could join the exhaustion test.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that all authors concur with the submission of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors of the given manuscript has any conflicts of financial interest to disclose regarding the aforementioned study. The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}